Condition: Lung Cancer · Sponsor: University of Pittsburgh
The purpose of this research study is to determine the genetic changes and immunologic changes that are involved in the development and progression of bronchogenic lung cancer.
This description comes directly from the study's public registry record.
Arjun Pennathur, MD · 412-647-7555 · pennathura@upmc.edu
Julie Ward, BSN · 412-647-8583 · wardj@upmc.edu
Always discuss trial participation with your own doctor first.
| Hillman Cancer Center | Pittsburgh, Pennsylvania, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT00280202